Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Walker

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
Science (New York, N.Y.)|April 1, 1988
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individualsB D Walker, C Flexner, T J Paradis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cellsR P Johnson, A Trocha, L Yang, et al.
The Journal of Clinical Investigation|November 1, 1995
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine releaseM J Koziel, D Dudley, N Afdhal, et al.
Journal of Virology|September 1, 1996
Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytesO O Yang, S A Kalams, M Rosenzweig, et al.
Journal of Virology|July 10, 1999
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapyS A Kalams, P J Goulder, A K Shea, et al.
Journal of Virology|January 11, 2001
Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCVD K Wong, D D Dudley, P B Dohrenwend, et al.
Journal of Virology|June 23, 2000
Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytesM E Severino, N V Sipsas, P T Nguyen, et al.
Journal of Virology|May 11, 1999
Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4O O Yang, S L Swanberg, Z Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermineB D Walker, M Kowalski, W C Goh, et al.
The Journal of Infectious Diseases|May 1, 1989
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidineV A Johnson, M A Barlow, T C Chou, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
Science (New York, N.Y.)|April 1, 1988
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individualsB D Walker, C Flexner, T J Paradis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cellsR P Johnson, A Trocha, L Yang, et al.
The Journal of Clinical Investigation|November 1, 1995
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine releaseM J Koziel, D Dudley, N Afdhal, et al.
Journal of Virology|September 1, 1996
Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytesO O Yang, S A Kalams, M Rosenzweig, et al.
Journal of Virology|July 10, 1999
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapyS A Kalams, P J Goulder, A K Shea, et al.
Journal of Virology|January 11, 2001
Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCVD K Wong, D D Dudley, P B Dohrenwend, et al.
Journal of Virology|June 23, 2000
Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytesM E Severino, N V Sipsas, P T Nguyen, et al.
Journal of Virology|May 11, 1999
Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4O O Yang, S L Swanberg, Z Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermineB D Walker, M Kowalski, W C Goh, et al.
The Journal of Infectious Diseases|May 1, 1989
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidineV A Johnson, M A Barlow, T C Chou, et al.
Pageof 17